| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1320872 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RFC4 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1320872 | 6480464 | Ethinyl Estradiol results in increased expression of RFC4 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of RFC4 mRNA | CTD | PMID:23019147 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1320872 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RFC4 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RFC4 mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1320872 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RFC4 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1310142 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RFC4 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RFC4 mRNA | CTD | PMID:21802500 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1310142 | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of RFC4 mRNA] | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1320872 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RFC4 mRNA | CTD | PMID:19465110 |
| 2,3-dimethoxynaphthalene-1,4-dione | increases expression | EXP | | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in increased expression of RFC4 mRNA | CTD | PMID:19031421 |
| 2-butoxyethanol | increases expression | ISO | RGD:1320872 | 6480464 | n-butoxyethanol results in increased expression of RFC4 mRNA | CTD | PMID:19812364 |
| 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of RFC4 mRNA | CTD | PMID:21179406 |
| 3-methylcholanthrene | increases expression | ISO | RGD:1320872 | 6480464 | Methylcholanthrene results in increased expression of RFC4 mRNA | CTD | PMID:20713471 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1320872 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of RFC4 mRNA | CTD | PMID:18648102 |
| 5-aza-2'-deoxycytidine | affects methylation | EXP | | 6480464 | decitabine affects the methylation of RFC4 gene | CTD | PMID:17630775 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of RFC4 mRNA] | CTD | PMID:15016801 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of RFC4 protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of RFC4 mRNA | CTD | PMID:22100608 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of RFC4 mRNA | CTD | PMID:17879257 |
| benzo[a]pyrene | increases expression | ISO | RGD:1320872 | 6480464 | Benzo(a)pyrene results in increased expression of RFC4 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of RFC4 mRNA | CTD | PMID:21802500 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1320872 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of RFC4 mRNA; more ... | CTD | PMID:21715664 |
| calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of RFC4 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RFC4 mRNA | CTD | PMID:21592394 |
| cefaloridine | increases expression | ISO | RGD:1310142 | 6480464 | Cephaloridine results in increased expression of RFC4 mRNA | CTD | PMID:18500788 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of RFC4 mRNA | CTD | PMID:19320972 PMID:19376846 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RFC4 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RFC4 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of RFC4 mRNA | CTD | PMID:19549813 |
| corticosterone | decreases expression | ISO | RGD:1310142 | 6480464 | Corticosterone results in decreased expression of RFC4 mRNA | CTD | PMID:15755911 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC4 mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of RFC4 mRNA | CTD | PMID:19167446 |
| cyclosporin A | affects expression | EXP | | 6480464 | Cyclosporine affects the expression of RFC4 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of RFC4 mRNA | CTD | PMID:21632981 |
| dasatinib (anhydrous) | decreases expression | EXP | | 6480464 | dasatinib results in decreased expression of RFC4 mRNA | CTD | PMID:20579391 |
| dibutyl phthalate | decreases expression | ISO | RGD:1320872 | 6480464 | Dibutyl Phthalate results in decreased expression of RFC4 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:1320872 | 6480464 | Dibutyl Phthalate results in decreased expression of RFC4 mRNA | CTD | PMID:17361019 PMID:21266533 |
| hydrogen peroxide | decreases secretion | ISO | RGD:1320872 | 6480464 | Hydrogen Peroxide results in decreased secretion of RFC4 mRNA | CTD | PMID:21179422 |
| indole-3-methanol | affects expression | ISO | RGD:1310142 | 6480464 | indole-3-carbinol affects the expression of RFC4 mRNA | CTD | PMID:21396975 |
| menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of RFC4 mRNA | CTD | PMID:20044591 |
| mitomycin C | decreases expression | EXP | | 6480464 | Mitomycin results in decreased expression of RFC4 mRNA | CTD | PMID:12760830 |
| ochratoxin A | decreases expression | ISO | RGD:1310142 | 6480464 | ochratoxin A results in decreased expression of RFC4 mRNA | CTD | PMID:22124623 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of RFC4 mRNA | CTD | PMID:22124623 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RFC4 mRNA | CTD | PMID:21420995 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of RFC4 mRNA | CTD | PMID:22230336 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of RFC4 mRNA | CTD | PMID:19159669 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of RFC4 mRNA | CTD | PMID:19031421 |
| pirinixic acid | increases expression | ISO | RGD:1320872 | 6480464 | pirinixic acid results in increased expression of RFC4 mRNA | CTD | PMID:18301758 |
| pirinixic acid | increases expression | ISO | RGD:1310142 | 6480464 | pirinixic acid results in increased expression of RFC4 mRNA | CTD | PMID:19162173 PMID:22484513 |
| pirinixic acid | increases expression | ISO | RGD:1310142 | 6480464 | pirinixic acid results in increased expression of RFC4 mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:1310142 | 6480464 | Pregnenolone Carbonitrile results in increased expression of RFC4 mRNA | CTD | PMID:19162173 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of RFC4 mRNA | CTD | PMID:21632981 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of RFC4 mRNA | CTD | PMID:15767336 |
| resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of RFC4 mRNA | CTD | PMID:19167446 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of RFC4 mRNA | CTD | PMID:18191903 |
| sodium dichromate | decreases expression | EXP | | 6480464 | sodium bichromate results in decreased expression of RFC4 mRNA | CTD | PMID:12760830 |
| testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RFC4 mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of RFC4 mRNA | CTD | PMID:21592394 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of RFC4 mRNA | CTD | PMID:15767336 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of RFC4 mRNA | CTD | PMID:19167446 |
| trimellitic anhydride | increases expression | ISO | RGD:1320872 | 6480464 | trimellitic anhydride results in increased expression of RFC4 mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of RFC4 mRNA | CTD | PMID:19140230 |
| vancomycin | decreases expression | ISO | RGD:1320872 | 6480464 | Vancomycin results in decreased expression of RFC4 mRNA | CTD | PMID:18930951 |